首页> 外国专利> Cinolin - 3 - carboxamide Derivatives, Methods for their preparation, Pharmaceutical compositions containing them and their use in the manufacture of medicaments for the treatment of diseases mediated by the Modulation of Gabaa receptor

Cinolin - 3 - carboxamide Derivatives, Methods for their preparation, Pharmaceutical compositions containing them and their use in the manufacture of medicaments for the treatment of diseases mediated by the Modulation of Gabaa receptor

机译:Cinolin-3-羧酰胺衍生物,其制备方法,包含它们的药物组合物及其在制备用于治疗由Gabaa受体介导的疾病的药物中的用途

摘要

These compounds are used to treat or prevent anxiety disorders, disorders, and / or mental disorders. They are also used in pharmaceutical synthesis and in the manufacture of GABA based drugs. In addition, a comprehensive approach is provided. Item 1: a formula compound (1)or one of its pharmaceutically acceptable salts, tautomers, atropisomers or in vivo hydrolyzable precursors, where R1 is C1-6 alkyl, C1-6 haloalkyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl, with 1, 2, 3, 4 or 5 R7; R2 is H, C (= O) Rb, C (= O) NRcRd, C (O) ORa, S (O) 2Rb, C1-6 alkyl, C1-6 haloalkyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl, where each of C 1-6 alkyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl,cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with 1, 2, 3, 4 or 5 R8; R3, R4 and R5 are each, independently, H, halo, Si (C1-10 alkyl) 3, CN, NO2, ORa, SRa, OC (= O) Ra, OC (= O) ORb, OC ( = O) NRcRCd, C (= O) Ra, C (= O) ORb, C (= O) NRcRd, NRcRd, NRcC (= O) Ra, N RcC (O) ORb, NRcS (O) 2Rb, S ( = O) Ra, S (= O) NRcRd, S (= O) 2Ra, S (= O) 2NRcRd, C1-6 alkyl, C1-6 haloalkyl, C2-6 alkenyl, C2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl, where C1-6alkyl, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl,One, two or three R9 can be selected to replace the heteromorphic tequila, ring clathra or non ring methyltequila; R6 is arilo, ring methylquinolo, heteromorphic or isopropyllu, and one, two, three, four or five A1 can be selected to replace each; R7, R8 and R9 are halogenated, C1-4 tar, C1-4 halotar, arilo and ring methylquinoi respectively, Straight, straight, straightMadam,This is my life.C (3DO) NRc Rdit is life.OC (3DO) RbOC (3DO) NRc RdNRC'RD',NRc C (3DO) RbNRc C (3DO) ORaNRc S (3DO) 2RbYes, that's it.S (3DO) NRc RdS (3DO) 2Rb o S (3DO) 2NRc Rd { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { C1-4, amino acid, c1-4-amino acid, diaquil c2-4-amino, C1-6, alquenilo c2-6, c12-6, acquinio c2-6, arilalquilo, cyclo clalquilo, Non-n-propyl, non-n-propyltequila, arillo, cyclopropyl, non-n-propyl or non-n-propyl coagulation, in which each type of C1-6, alquenilo c2-6, tar layer c2-6, arilalquilo, cyclopropyllong, isopropyllong, arillo, cyclopropyllu, non cyclopropyllong, isopropyltequila, heterogeneous or non cyclopentadienedienediallyoxybenzene is replaced.4 or 5. Independently selected halogenated, C1-6 tar, c2-6 alquenilo c2-6, c2-6 tar, C1-4 halogenated, arilo, cyclopentanediol, isopropene, isoacrylonitrile, isopropyl propylene, CN, NO2, ora substitutes,Madam,This is my life.C (3DO) NRc Rdit is life.OC (3DO) RbOC (3DO) NRc RdNRC'RD',NRc C (3DO) RbNRc C (3DO) ORaNRc S (3DO) RbNRc S (3DO) 2RbYes, that's it.S (O) NRc RdS (3DO) 2Rb o S (3DO) 2Rc RdRA and RA's are h, C1-6, C1-6, C1-6, c12-6, alquenilo c2-6, c12-6, acrylonitrile, isopropyl, isopropyl, isopropyl propyl, arilalquilo, isoacrylonitrile, cyclopentadiene, cyclopentadienediallyl methanol or isopropyl propyl methanol, respectively, of which C1-6, C1-6 halo-6, alquenilo c2-6, c2-6, C2 Isopropylene, isopropenylpropene, isopropenylpropene, cyclopropene or isopropenylpropenyl propenyl propenyl propenyl propenyl propenyl propenyl propenyl propenyl propenyl propenyl propenyl propenyl propenyl propenyl propenyl propenyl propenyl propenyl propylpropylpropylpropylpropylpropyl propenyl propenyl propenyl propenyl propylpropylpropylpropylC1-6 haloalkyl, C2-6 alkenyl, C2-6 alkynyl, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl, where C1-6 alkyl, C2-6alkenyl, C2-6alkenyl, -6, aryl, cycloalkyl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with OH, amino, halo, C1-6alkyl, haloC1-6alkyl, aryl, arylalkyl, heteroaryl, , cycloalkyl or heterocycloalkyl; Rc and Rd are each independently H, C1-10 alkyl, C1-6 haloalkyl, C2-6 alkenyl, C2-6 alkynyl, aryl,Right angle, ring armour, non ring armour, non ring armour, arilachilo, alien, ring armour, ring armour carat or non ring armour carat Cyclomequilol or non cyclomequilol can be replaced by Oh, amino, halo, C1-6 asphalt, C1-6 halo tar, C1-6 halo tar, arilo, arilalquilo, heterosexual, heterosexual, cyclomequilol or non cyclomequilol; or RC and RD can form a non cyclomequilol compound with N atoms, 6 or 7 members; RC 'and RD's are independent members, h,C 1-10 alkyl, C 1-6 haloalkyl, C 2-6 alkenyl, C 2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl, where C 1-10 alkyl, C 1-6 haloalkyl, -6, C2-6 alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or heterocycloalkylalkyl is optionally substituted with OH, amino, halo, C1-6alkyl, haloalkyl, aryl, heteroaryl, heteroaryl, , cycloalkyl or heterocycloalkyl; or Rc 'and Rd' together with the N atom to which they are attached form a 4-, 5-, 6-, or 7-membered heterocycloalkyl group;The condition is that when R2, R3, R4 and R5 are h, R6 is different from the unmodified phenyl or the unmodified cyclopentyl.
机译:这些化合物用于治疗或预防焦虑症,疾病和/或精神疾病。它们还用于药物合成和基于GABA的药物的生产。另外,提供了一种综合方法。第1项:式化合物(1)或其药学上可接受的盐,互变异构体,阻转异构体或体内可水解的前体之一,其中R 1为C 1-6烷基,C 1-6卤代烷基,芳基,杂芳基,环烷基,杂环烷基,芳基烷基,杂芳基烷基,具有1、2、3、4或5个R 7的环烷基烷基或杂环烷基烷基; R 2是H,C(= O)Rb,C(= O)NRcRd,C(O)ORa,S(O)2Rb,C1-6烷基,C1-6卤代烷基,芳基,杂芳基,环烷基,杂环烷基,芳基烷基,杂芳基烷基,环烷基烷基或杂环烷基烷基,其中C 1-6烷基,芳基,杂芳基,环烷基,杂环烷基,芳基烷基,杂芳基烷基,环烷基烷基或杂环烷基烷基各自任选地被1、2、3、4或5个R8取代; R 3,R 4和R 5分别独立地是H,卤素,Si(C1-10烷基)3,CN,NO2,ORa,SRa,OC(= O)Ra,OC(= O)ORb,OC(= O) NRcRCd,C(= O)Ra,C(= O)ORb,C(= O)NRcRd,NRcRd,NRcC(= O)Ra,N RcC(O)ORb,NRcS(O)2Rb,S(= O) Ra,S(= O)NRcRd,S(= O)2 Ra,S(= O)2NRcRd,C 1-6烷基,C 1-6卤代烷基,C 2-6烯基,C 2-6炔基,芳基,环烷基,杂芳基,杂环烷基,芳基烷基,杂芳基烷基,环烷基烷基或杂环烷基烷基,其中C 1-6烷基,C 1-6烷基,C 2-6烯基,C 2-6炔基,芳基,环烷基,杂芳基,杂环烷基,芳基烷基,可以选择一个,两个或三个R9来取代异形龙舌兰酒,环网状或非环甲基龙舌兰酒; R6是芳基,环甲基喹啉基,杂晶或异丙基,可以选择1、2、3、4或5个A1取代。 R7,R8和R9分别是卤代,C1-4焦油,C1-4卤代,芳基和环甲基喹啉,直,直,直女士,这就是我的生活.C(3DO)NRc Rdit是生活.OC(3DO)RbOC( 3DO)NRc RdNRC'RD',NRc C(3DO)RbNRc C(3DO)ORaNRc S(3DO)2Rb是的,就是这样.S(3DO)NRc RdS(3DO)2Rb o S(3DO)2NRc Rd { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { { C1-4,氨基酸,c1- 4-氨基酸,diaquil c2-4-氨基,C1-6,alquenilo c2-6,c12-6,acquinio c2-6,alilalquilo,cyclo clalquilo,非正丙基,非正丙基龙舌兰,阿里洛,环丙基,非正丙基或非正丙基混凝,其中每种类型的C1-6,alquenilo c2-6,焦油层c2-6,alilalquilo,cyclopropyllong,isopropyllong,arillo,cyclopropyllu,noncyclopropyllong,isopropyltequila,异质或非环戊二烯二烯丙基乙氧基苯被取代。4或5。锯齿状,C1-6焦油,c2-6阿尔奎尼洛c2-6,c2-6焦油,卤化C1-4,芳基,环戊二醇,异丙基,异丙烯腈,异丙基丙烯,CN,NO2,ora替代品,女士,这是我的生活。 C(3DO)NRc Rdit是生命.OC(3DO)RbOC(3DO)NRc RdNRC'RD',NRc C(3DO)RbNRc C(3DO)ORaNRc S(3DO)RbNRc S(3DO)2Rb是,就是这样。 O)NRc RdS(3DO)2Rb o S(3DO)2Rc RdRA和RA是h,C1-6,C1-6,C1-6,c12-6,alquenilo c2-6,c12-6,丙烯腈,异丙基,异丙基分别为C1-6,C1-6卤代-6,alquenilo c2-6,c2-6,C2异丙烯,异丙烯基丙烯,异丙烯基丙烯,环丙烯或异丙基,异丙基丙基,芳丙基,异丙烯腈,环戊二烯,环戊二烯丙基甲醇或异丙基丙基甲醇异丙烯基丙烯基丙烯基丙烯基丙烯基丙烯基丙烯基丙烯基丙烯基丙烯基丙烯基丙烯基丙烯基丙烯基丙烯基丙烯基丙烯基丙烯基丙基丙基C1-6卤代烷基,C2-6烯基,C2-6炔基,芳基,环烷基,杂芳基,杂环烷基,芳基烷基,杂芳基烷基,环烷基烷基或杂环烷基烷基,其中C1-6烷基,C2-6烯基,C2-6烯基,-6,芳基,环烷基,杂芳基,杂环烷基,芳基烷基,杂芳基烷基,环烷基烷基或杂环烷基烷基任选地被OH,氨基,卤素,C 1-6烷基,卤代C 1-6烷基,芳基,芳基烷基,杂芳基,环烷基或杂环烷基取代; Rc和Rd分别独立为H,C1-10烷基,C1-6卤代烷基,C2-6烯基,C2-6炔基,芳基,直角,环铠,非环铠,非环铠,芳构,外星人,环铠,环甲克拉或非环甲克拉Cyclomequilol或非环美喹啉可以替换为Oh,氨基,卤素,C1-6沥青,C1-6卤素焦油,C1-6卤素焦油,arilo,alilalquilo,异性恋,异性恋,环美喹啉或非环美洛尔RC和RD可以形成具有6个或7个N原子的非环甲酚化合物; RC'和RD'是独立成员,h,C 1-10烷基,C 1-6卤代烷基,C 2-6烯基,C 2-6炔基,芳基,杂芳基,环烷基,杂环烷基,芳基烷基,杂芳基烷基,环烷基烷基或杂环烷基烷基,其中C 1-10烷基,C 1-6卤代烷基,-6,C2-6炔基,芳基,杂芳基,环烷基,杂环烷基,芳基烷基,杂芳基烷基,环烷基烷基或杂环烷基烷基可选地被OH,氨基,卤素,C1-6烷基取代,卤代烷基,芳基,杂芳基,杂芳基,环烷基或杂环烷基;或Rc'和Rd'与它们所连接的N原子一起形成4、5、6或7元杂环烷基;条件是当R2,R3,R4和R5为h时,R6与未改性的苯基或未改性的环戊基不同。

著录项

  • 公开/公告号AR056892A1

    专利类型

  • 公开/公告日2007-10-31

    原文格式PDF

  • 申请/专利权人 ASTRA AKTIEBOLAG;

    申请/专利号AR2006P105619

  • 发明设计人

    申请日2006-12-19

  • 分类号C07D237/28;C07D401/04;C07D403/04;A61K31/502;A61P25/16;A61P25/22;A61P25/28;

  • 国家 AR

  • 入库时间 2022-08-21 20:59:35

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号